AIMS-2-TRIALS: Autism Innovative Medicine Studies – 2 – Trials
Kas, M., Riemersma, I. & Østergaard, F.
01/06/2018 → 01/06/2023
AIMS-2-TRIALS aims to improve outcomes for people with ASD. To do this it will create a pipeline for developing, testing and implementing new treatments for ASD with stakeholder involvement at each stage. The project will set up a global clinical trial network for ASD to validate biological markers and endpoints to reliably show whether or not a treatment is effective and appropriate for ASD.
The project brings together experts from universities, university hospitals, pharmaceutical companies, patient groups, not-for-profit foundations, and small and medium-sized enterprises.
|Effective start/end date||01/06/2018 → 01/06/2023|
Related Press / Media
01/04/2012 → 01/04/2018